Company profile: Vesalius Therapeutics
1.1 - Company Overview
Company description
- Provider of the ContinuumDiscovery platform, which identifies clinical patterns in patient groups, links these patterns to gene circuits, and screens drug candidates to restore circuits to healthy functioning; focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
Products and services
- ContinuumDiscovery™ platform: Pattern-recognition-driven platform that identifies clinical patterns across patient groups, links these patterns to gene circuits, and screens drug candidates to restore circuits to healthy functioning
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vesalius Therapeutics
Emerald Cloud Lab
HQ: United States
Website
- Description: Provider of technology platforms for biotechnology innovation, including ECL Command Center for remote experiment design and execution; ECL Constellation for organizing data into a knowledge graph; access to 200+ automated lab instruments (HPLC, Mass Spectrometry, NMR); and 4,500+ data visualization, analysis, and simulation functions via point-and-click or direct command entry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emerald Cloud Lab company profile →
Benchling
HQ: United States
Website
- Description: Provider of a cloud-based platform for biology researchers and R&D organizations, including the Benchling R&D Cloud to centralize and standardize scientific data, enable collaboration, and provide insights; Benchling Bioresearch to design and manage experiments, biomolecules, workflows, and results; Benchling Notebook; plus CRISPR guide RNA design and sequence alignment tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Benchling company profile →
Asimov
HQ: United States
Website
- Description: Provider of AI-enabled synthetic biology platforms and tools for designing and manufacturing next-generation therapeutics, offering the CHO Edge System for biologics production, LV Edge System for lentiviral production, a Genetic Design Platform, Cello for computer-aided genetic design, and the ASKE AI design engine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Asimov company profile →
Abbott
HQ: United States
Website
- Description: Provider of lab data management solutions, including LIMS, SDMS, and ELN, that integrate with current systems and can be rapidly configured to fit unique workflows without adding complexity or interrupting daily operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abbott company profile →
Viedoc
HQ: Sweden
Website
- Description: Provider of engaging software that modernizes clinical research, offering tools for study design (drag-and-drop forms, preview, template library), site and user administration, trial data management with real-time metrics and batch mode, ePRO/eCOA for participant self-reporting, decentralized trials (eConsent, screen sharing, video calls), and supply logistics with real-time inventory visibility and alerts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viedoc company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vesalius Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vesalius Therapeutics
2.2 - Growth funds investing in similar companies to Vesalius Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vesalius Therapeutics
4.2 - Public trading comparable groups for Vesalius Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →